The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
Cell permeability beyond the rule of 5
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
A hierarchical approach to all‐atom protein loop prediction
Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10613 · Cited by 2,504
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
Quantifying the chemical beauty of drugs
Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012) · Nature Chemistry · doi:10.1038/nchem.1243 · Cited by 2,242
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Prediction of Drug Absorption Using Multivariate Statistics
Egan, W. J., Merz, & Baldwin, J. J. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000292e · Cited by 1,970
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Artursson, P., Palm, K., & Luthman, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00128-9 · Cited by 1,543
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
The exploration of macrocycles for drug discovery — an underexploited structural class
Driggers, E. M., Hale, S. P., Lee, J., & Terrett, N. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2590 · Cited by 1,370
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
The role of ligand efficiency metrics in drug discovery
Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
Arkin, M. R., Tang, Y., & Wells, J. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.001 · Cited by 1,065
MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening
Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Grove, J. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9803205 · Cited by 980
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Lipophilicity in drug discovery
Waring, M. J. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441003605098 · Cited by 873
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
Doak, B. C., Over, B., Giordanetto, F., & Kihlberg, J. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.08.013 · Cited by 835
Self-citationSLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
Human ATP-binding cassette (ABC) transporter family
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 780
Crystal structure of the human glucose transporter GLUT1
Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N. (2014) · Nature · doi:10.1038/nature13306 · Cited by 777
Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans
Palm, K., Stenberg, P., Luthman, K., & Artursson1, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012188625088 · Cited by 756
Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
Polli, J. W., Wring, S. A., Humphreys, J. E., Huang, L., Morgan, J. B., Webster, L. O., & Serabjit-Singh, C. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29270-3 · Cited by 662
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
The ABCs of membrane transporters in health and disease (SLC series): Introduction
Hediger, M. A., Clémençon, B., Burrier, R. E., & Bruford, E. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.009 · Cited by 646
Meanwell, N. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200211v · Cited by 620
A Call for Systematic Research on Solute Carriers
César-Razquin, A., Snijder, B., Frappier-Brinton, T., Isserlin, R., Gyimesi, G., Bai, X., Reithmeier, R. A., Hepworth, D., Hediger, M. A., Edwards, A. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.022 · Cited by 580
Intramolecular Hydrogen Bonding in Medicinal Chemistry
Kuhn, B., Mohr, P., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100087s · Cited by 571
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
Giordanetto, F., & Kihlberg, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400887j · Cited by 563
Self-citationA general pattern for substrate recognition by P‐glycoprotein
Seelig, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510252.x · Cited by 527
Young, R. C., Mitchell, R. C., Brown, T. H., Ganellin, C. R., Griffiths, R., Jones, M., Rana, K. K., Saunders, D., & Smith, I. R. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00398a028 · Cited by 521
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., & Lokey, R. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0563455 · Cited by 490
Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Dobson, P. D., & Kell, D. B. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2438 · Cited by 475
Can we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Macrocycles In New Drug Discovery
Mallinson, J., & Collins, I. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.93 · Cited by 468
Steinbeck, C., Hoppe, C., Kuhn, S., Floris, M., Guha, R., & Willighagen, E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777585274 · Cited by 462
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
Li, Y., Theuretzbacher, U., Clancy, C. J., Nguyen, M. H., & Derendorf, H. (2010) · Clinical Pharmacokinetics · doi:10.2165/11319340-000000000-00000 · Cited by 450
A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation
Singh, S. K., Piscitelli, C. L., Yamashita, A., & Gouaux, E. (2008) · Science · doi:10.1126/science.1166777 · Cited by 431
Drug discovery beyond the ‘rule-of-five’
Zhang, M.-Q., & Wilkinson, B. (2007) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2007.10.005 · Cited by 418
Rezai, T., Bock, J. E., Zhou, M. V., Kalyanaraman, C., Lokey, R. S., & Jacobson, M. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063076p · Cited by 416
Correlation of Drug Absorption with Molecular Surface Properties
Palm, K., Luthman, K., Unge, A.-L., Strandlund, G., & Artursson, P. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950285r · Cited by 412
Villar, E. A., Beglov, D., Chennamadhavuni, S., Porco, J. A., Kozakov, D., Vajda, S., & Whitty, A. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1584 · Cited by 400
Using the Golden Triangle to optimize clearance and oral absorption
Johnson, T. W., Dress, K. R., & Edwards, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.045 · Cited by 392
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
White, T. R., Renzelman, C. M., Rand, A. C., Rezai, T., McEwen, C. M., Gelev, V. M., Turner, R. A., Linington, R. G., Leung, S. S. F., Kalgutkar, A. S., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.664 · Cited by 386
Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues
Biron, E., Chatterjee, J., Ovadia, O., Langenegger, D., Brueggen, J., Hoyer, D., Schmid, H. A., Jelinek, R., Gilon, C., Hoffman, A., et al. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705797 · Cited by 374
Molecular obesity, potency and other addictions in drug discovery
Hann, M. M. (2011) · MedChemComm · doi:10.1039/c1md00017a · Cited by 363
Cyclosporin Clinical Pharmacokinetics
Fahr, A. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324060-00004 · Cited by 356
Hillgren, K. M., Keppler, D., Zur, A. A., Giacomini, K. M., Stieger, B., Cass, C. E., & Zhang, L. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.74 · Cited by 352
Prediction of intestinal permeability
Egan, W. J., & Lauri, G. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00004-2 · Cited by 344
How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets
Doak, B. C., Zheng, J., Dobritzsch, D., & Kihlberg, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01286 · Cited by 335
Self-citationAlex, A., Millan, D. S., Perez, M., Wakenhut, F., & Whitlock, G. A. (2011) · MedChemComm · doi:10.1039/c1md00093d · Cited by 329
Caco-2 monolayers in experimental and theoretical predictions of drug transport
Artursson, P., Palm, K., & Luthman, K. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00415-2 · Cited by 326
Going further than Lipinski's rule in drug design
Walters, W. P. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.648612 · Cited by 306
Gertz, M., Harrison, A., Houston, J. B., & Galetin, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032649 · Cited by 297
Rask-Andersen, M., Masuram, S., & Schiöth, H. B. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135943 · Cited by 282
Permeation of Small Molecules through a Lipid Bilayer: A Computer Simulation Study
Bemporad, D., Essex, J. W., & Luttmann, C. (2004) · The Journal of Physical Chemistry B · doi:10.1021/jp035260s · Cited by 278
Summa, V., Ludmerer, S. W., McCauley, J. A., Fandozzi, C., Burlein, C., Claudio, G., Coleman, P. J., DiMuzio, J. M., Ferrara, M., Di Filippo, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-12 · Cited by 259
Getting pharmaceutical R&D back on target
Bunnage, M. E. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.581 · Cited by 258
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges
Montanari, F., & Ecker, G. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.001 · Cited by 257
Ward, A. B., Szewczyk, P., Grimard, V., Lee, C.-W., Martinez, L., Doshi, R., Caya, A., Villaluz, M., Pardon, E., Cregger, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309275110 · Cited by 256
The graphical representation of ADME-related molecule properties for medicinal chemists
Ritchie, T. J., Ertl, P., & Lewis, R. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.002 · Cited by 249
Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
Surade, S., & Blundell, T. L. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.013 · Cited by 230
P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design
Raub, T. J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500871 · Cited by 221
Cell-Permeable Cyclic Peptides from Synthetic Libraries Inspired by Natural Products
Hewitt, W. M., Leung, S. S. F., Pye, C. R., Ponkey, A. R., Bednarek, M., Jacobson, M. P., & Lokey, R. S. (2015) · Journal of the American Chemical Society · doi:10.1021/ja508766b · Cited by 210
Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
Terwogt, J. M. M., Malingré, M. M., Beijnen, J. H., Huinink, W. W. T. B., Rosing, H., Koopman, F. J., van Tellingen, O., Swart, M., & Schellens, J. H. M. (1999) · PubMed · Cited by 205
Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors
van De Waterbeemd, H., Camenisch, G., Folkers, G., & Raevsky, O. A. (1996) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19960150604 · Cited by 200
Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L.-B., Yasuda, K., Shepard, R. L., Winter, M. A., Schuetz, J. D., et al. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12192-x · Cited by 191
Intestinal Permeability of Cyclic Peptides: Common Key Backbone Motifs Identified
Beck, J. G., Chatterjee, J., Laufer, B., Kiran, M. U., Frank, A. O., Neubauer, S., Ovadia, O., Greenberg, S., Gilon, C., Hoffman, A., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303200d · Cited by 187
Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective
Bockus, A. T., McEwen, C. M., & Lokey, R. S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313070005 · Cited by 187
Ahlbach, C. L., Lexa, K. W., Bockus, A. T., Chen, V., Crews, P., Jacobson, M. P., & Lokey, R. S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.78 · Cited by 178
Wang, C. K., Northfield, S. E., Colless, B., Chaousis, S., Hamernig, I., Lohman, R.-J., Nielsen, D. S., Schroeder, C. I., Liras, S., Price, D. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417611111 · Cited by 171
Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
Di, L., Artursson, P., Avdeef, A., Ecker, G. F., Faller, B., Fischer, H., Houston, J. B., Kansy, M., Kerns, E. H., Krämer, S. D., et al. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.015 · Cited by 167
Prediction of P-Glycoprotein Substrates by a Support Vector Machine Approach
Xue, Y., Yap, C. W., Sun, L. Z., Cao, Z. W., Wang, J. F., & Chen, Y. Z. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci049971e · Cited by 159
Exploring the Role of Different Drug Transport Routes in Permeability Screening
Matsson, P., Bergström, C. A. S., Nagahara, N., Tavelin, S., Norinder, U., & Artursson, P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049711o · Cited by 147
Self-citationImproving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable
Nielsen, D. S., Hoang, H. N., Lohman, R., Hill, T. A., Lucke, A. J., Craik, D. J., Edmonds, D. J., Griffith, D. A., Rotter, C. J., Ruggeri, R. B., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201405364 · Cited by 147
Bockus, A. T., Lexa, K. W., Pye, C. R., Kalgutkar, A. S. S., Gardner, J. W., Hund, K. C. R., Hewitt, W. M., Schwochert, J. A., Glassey, E., Price, D. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00128 · Cited by 147
How hydrogen bonds impact P-glycoprotein transport and permeability
Desai, P. V., Raub, T. J., & Blanco, M.-J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.059 · Cited by 141
Li, D., Chen, L., Li, Y., Tian, S., Sun, H., & Hou, T. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400450m · Cited by 141
Jiang, Y., Andrews, S. W., Condroski, K. R., Buckman, B. O., Serebryany, V., Wenglowsky, S., Kennedy, A. L., Madduru, M. R., Wang, B., Lyon, M. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400164c · Cited by 141
Yang, Y., Engkvist, O., Llinàs, A., & Chen, H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201548z · Cited by 139
Hopkins, S., Scorneaux, B., Huang, Z., Murray, M. G., Wring, S. A., Smitley, C., Harris, R. W., Erdmann, F., Fischer, G. S., & Ribeill, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00660-09 · Cited by 139
Williamson, B., Dooley, K. E., Zhang, Y., Back, D. J., & Owen, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01124-13 · Cited by 138
Bockus, A. T., Schwochert, J. A., Pye, C. R., Townsend, C. E., Sok, V., Bednarek, M. A., & Lokey, R. S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00919 · Cited by 135
ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
Perloff, E. S., Duan, S. X., Skolnik, P. R., Greenblatt, D. J., & Moltke, L. L. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002931 · Cited by 134
Rand, A. C., Leung, S. S. F., Eng, H. F., Rotter, C. J., Sharma, R., Kalgutkar, A. S. S., Zhang, Y., Varma, M. V. S., Farley, K. A., Khunte, B., et al. (2012) · MedChemComm · doi:10.1039/c2md20203d · Cited by 132
How does P-glycoprotein recognize its substrates?
Ueda, K., Taguchi, Y., & Morishima, M. (1997) · Seminars in Cancer Biology · doi:10.1006/scbi.1997.0066 · Cited by 132
Testing Physical Models of Passive Membrane Permeation
Leung, S. S. F., Mijalkovic, J., Borrelli, K. W., & Jacobson, M. P. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200583t · Cited by 125
Cavet, M. E., West, M., & Simmons, N. L. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15550.x · Cited by 124
Morphy, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0512185 · Cited by 123
Insights on P-Glycoprotein’s Efflux Mechanism Obtained by Molecular Dynamics Simulations
Ferreira, R. J., Ferreira, M. U., & dos Santos, D. J. V. A. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300083m · Cited by 123
Drug discovery in the next decade: innovation needed ASAP
Bennani, Y. L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.004 · Cited by 120
High Throughput Method for the Indirect Detection of Intramolecular Hydrogen Bonding
Goetz, G. H., Farrell, W. P., Shalaeva, M. Y., Sciabola, S., Anderson, D. P., Yan, J., Philippe, L., & Shapiro, M. J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401859b · Cited by 119
Predicting and Improving the Membrane Permeability of Peptidic Small Molecules
Rafi, S. B., Hearn, B. R., Vedantham, P., Jacobson, M. P., & Renslo, A. R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201634q · Cited by 117
Use of 3D Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation
Guimarães, C. R. W., Mathiowetz, A. M., Shalaeva, M. Y., Goetz, G. H., & Liras, S. I. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300010y · Cited by 117
Keogh, J. P., & Kunta, J. R. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.011 · Cited by 113
Comparison of human solute carriers
Schlessinger, A., Matsson, P., Shima, J. E., Pieper, U., Yee, S. W., Kelly, L., Apeltsin, L., Stroud, R. M., Ferrin, T. E., Giacomini, K. M., et al. (2010) · Protein Science · doi:10.1002/pro.320 · Cited by 113
Self-citationCharacterization of Two Pharmacophores on the Multidrug Transporter P-Glycoprotein
Garrigues, A., Loiseau, N., Delaforge, M., Ferté, J., Garrigos, M., André, F., & Orlowski, S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1288 · Cited by 109
Kalvass, J. C., & Pollack, G. M. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9135-x · Cited by 109
P-glycoprotein Substrate Models Using Support Vector Machines Based on a Comprehensive Data set
Wang, Z., Chen, Y., Hu, L., Bender, A., Glen, R. C., & Yan, A. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2001583 · Cited by 108
Dependence of Molecular Properties on Proteomic Family for Marketed Oral Drugs
Vieth, M., & Sutherland, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603825 · Cited by 103
Sedykh, A., Fourches, D., Duan, J., Hucke, O., Garneau, M., Zhu, H., Bonneau, P. R., & Tropsha, A. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0935-x · Cited by 99
Desai, P. V., Sawada, G. A., Watson, I. A., & Raub, T. J. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300555n · Cited by 98
Wang, C. K. L., Northfield, S. E., Swedberg, J. E., Colless, B., Chaousis, S., Price, D. A., Liras, S. I., & Craik, D. J. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.049 · Cited by 97
Okumu, F. W., Pauletti, G. M., VanderVelde, D. G., Siahaan, T. J., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012092409216 · Cited by 94
Over, B., McCarren, P. R., Artursson, P., Foley, M. A., Giordanetto, F., Grönberg, G., Hilgendorf, C., Lee, M. D., Matsson, P., Muncipinto, G., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500059t · Cited by 90
Self-citationShalaeva, M. Y., Caron, G., Abramov, Y. A., O’Connell, T. N., Plummer, M. S., Yalamanchi, G., Farley, K. A., Goetz, G. H., Philippe, L., & Shapiro, M. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301850m · Cited by 89
Chang, C. K., Pang, K. S., Swaan, P. W., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082370 · Cited by 88
Omote, H., & Al‐Shawi, M. K. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.077743 · Cited by 87
Swift, R. V., & Amaro, R. E. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12074 · Cited by 86
Castillo‐Garit, J. A., Marrero‐Ponce, Y., Torrens, F., & García‐Domenech, R. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21122 · Cited by 86
Fingerprint-based in silico models for the prediction of P-glycoprotein substrates and inhibitors
Poongavanam, V., Haider, N., & Ecker, G. F. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.045 · Cited by 81
Structure of a multidrug transporter
Gottesman, M. M., Ambudkar, S. V., & Xia, D. (2009) · Nature Biotechnology · doi:10.1038/nbt0609-546 · Cited by 77
Pawarode, A., Shukla, S., Minderman, H., Fricke, S. M., Pinder, E., O’Loughlin, K. L., Ambudkar, S. V., & Baer, M. R. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0357-8 · Cited by 76
Ramsden, D., Tweedie, D., Chan, T. S., Taub, M. E., & Li, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055897 · Cited by 71
Kis, O., Zastre, J. A., Hoque, M. T., Walmsley, S. L., & Bendayan, R. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0942-y · Cited by 70
Identifying P-Glycoprotein Substrates Using a Support Vector Machine Optimized by a Particle Swarm
Huang, J., Ma, G., Ishtiaq, M., & Cheng, Y. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700083n · Cited by 69
Cyclic Penta- and Hexaleucine Peptides without N -Methylation Are Orally Absorbed
Hill, T. A., Lohman, R., Hoang, H. N., Nielsen, D. S., Scully, C. C. G., Kok, W. M., Liu, L., Lucke, A. J., Stoermer, M. J., Schroeder, C. I., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5002823 · Cited by 66
Thansandote, P., Harris, R. M., Dexter, H. L., Simpson, G. L., Pal, S., Upton, R. J., & Valko, K. L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.11.034 · Cited by 65
How does P-glycoprotein recognize its substrates?
Seelig, A. (1998) · PubMed · Cited by 64
Mechanism of multidrug resistance in relation to passive membrane permeation
Eytan, G. D. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.01.003 · Cited by 64
Ligand efficiency metrics considered harmful
Kenny, P. W., Leitão, A., & Montanari, C. A. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9757-8 · Cited by 63
Mak, L., Marcus, D., Howlett, A., Yarova, G., Duchateau, G. S. M. J. E., Klaffke, W., Bender, A., & Glen, R. C. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0083-5 · Cited by 61
Influence of Solute Carriers on the Pharmacokinetics of CYP3A4 Probes
Franke, R. M., Baker, S. D., Mathijssen, R. H. J., Schuetz, E., & Sparreboom, A. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.94 · Cited by 61
Ozawa, N., Shimizu, T., Morita, R., Yokono, Y., Ochiai, T., Munesada, K., Ōhashi, A., Aida, Y., Hama, Y., Taki, K., et al. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000048207.11160.d0 · Cited by 59
Kos, V. M., Kelnerić, Ž., Mikac, L., & Haber, V. E. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.05.016 · Cited by 58
Bogdan, A. R., Davies, N. L., & James, K. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05996c · Cited by 57
Hazai, E., Hazai, I., Ragueneau, I., Chung, S. P., Bikádi, Z., & Mao, Q. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-130 · Cited by 57
Development of a Rule-Based Method for the Assessment of Protein Druggability
Perola, E., Herman, L. W., & Weiss, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200613b · Cited by 56
A Sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond
Abad‐Zapatero, C. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.022 · Cited by 53
Bousquet, L., Roucairol, C., Hembury, A., Nevers, M., Créminon, C., Farinotti, R., & Mabondzo, A. M. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0022 · Cited by 50
Pachot, J. I., Botham, R. P., Haegele, K. D., & Hwang, K. (2003) · PubMed · Cited by 49
Enantiomeric Cyclic Peptides with Different Caco‐2 Permeability Suggest Carrier‐Mediated Transport
Marelli, U. K., Bezençon, J., Puig, E., Ernst, B., & Kessler, H. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201501270 · Cited by 45
Quantifying the impact of transporters on cellular drug permeability
Matsson, P., Fenu, L. A., Lundquist, P., Wiśniewski, J. R., Kansy, M., & Artursson, P. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.009 · Cited by 43
Self-citationLan, T., Rao, A., Haywood, J., Davis, C. B., Han, C., Garver, E. M., & Dawson, P. A. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028522 · Cited by 43
Garver, E. M., Hugger, E. D., Shearn, S. P., Rao, A., Dawson, P. A., Davis, C. B., & Han, C. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022285 · Cited by 40
Ferlini, C., Gallo, D., & Scambia, G. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.335 · Cited by 40
Ptachcinski, R. J., Burckart, G. J., & Venkataramanan, R. (1985) · Annals of Pharmacotherapy · doi:10.1177/106002808501900202 · Cited by 38
A General Model for Prediction of Caco‐2 Cell Permeability
Nordqvist, A., Nilsson, J. E., Lindmark, T., Eriksson, A., Garberg, P., & Kihlén, M. (2004) · QSAR & Combinatorial Science · doi:10.1002/qsar.200330868 · Cited by 37
Picard, N., Levoir, L., Lamoureux, F., Yee, S. W., Giacomini, K. M., & Marquet, P. (2011) · Xenobiotica · doi:10.3109/00498254.2011.573882 · Cited by 36
Lamoureux, F., Picard, N., Boussera, B., Sauvage, F., & Marquet, P. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00957.x · Cited by 34
Annotating Human P‐Glycoprotein Bioassay Data
Zdrazil, B., Pinto, M., Poongavanam, V., Williams, A. J., Balderud, L. Z., Engkvist, O., Chichester, C. H., Hersey, A., Overington, J. P., & Ecker, G. F. (2012) · Molecular Informatics · doi:10.1002/minf.201200059 · Cited by 32
Tran, T. D., Wakenhut, F., Pickford, C., Shaw, S. M., Westby, M., Smith‐Burchnell, C., Watson, L., Paradowski, M., Milbank, J. B. J., Brimage, R. A., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201400045 · Cited by 32
Roles of P-Glycoprotein, Bcrp, and Mrp2 in Biliary Excretion of Spiramycin in Mice
Tian, X., Li, J., Zamek‐Gliszczynski, M. J., Bridges, A. S., Zhang, P., Patel, N. J., Raub, T. J., Pollack, G. M., & Brouwer, K. L. R. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00082-07 · Cited by 32
Assessment of Macrolide Transport Using PAMPA, Caco-2 and MDCKII-hMDR1 Assays
Nožinić, D., Milić, A., Mikac, L., Ralić, J., Padovan, J., & Antolović, R. (2010) · University of Zagreb University Computing Centre (SRCE) · Cited by 31
Chemoinformatic Analysis of Biologically Active Macrocycles
Brandt, W., Haupt, V. J., & Wessjohann, L. A. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610792232060 · Cited by 30
Computational modeling to predict the functions and impact of drug transporters
Matsson, P., & Bergström, C. A. S. (2015) · In Silico Pharmacology · doi:10.1186/s40203-015-0012-3 · Cited by 25
Self-citationThe synthesis of novel taxoids for oral administration
Jing, Y., Zhou, W. J., Li, W.-L., Zhao, L., & Wang, Y. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.037 · Cited by 24
Jabeen, I., Wetwitayaklung, P., Klepsch, F., Parveen, Z., Chiba, P., & Ecker, G. F. (2010) · Chemical Communications · doi:10.1039/c0cc03075a · Cited by 23
Wakenhut, F., Tran, T. D., Pickford, C., Shaw, S. M., Westby, M., Smith‐Burchnell, C., Watson, L., Paradowski, M., Milbank, J. B. J., Stonehouse, D., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201400046 · Cited by 19
Investigating the barriers to bioavailability of macrolide antibiotics in the rat
Padovan, J., Ralić, J., Letfus, V., Milić, A., & Mihaljević, V. B. (2011) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-011-0074-5 · Cited by 16
Effect of macrolide antibiotics on uptake of digoxin into rat liver
Ito, S., Nasu, R., Tsujimoto, M., 村上, 秀., Ohtani, H., & Sawada, Y. (2007) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.537 · Cited by 10
Optimizing the Permeability and Oral Bioavailability of Macrocycles
Mathiowetz, A. M., Leung, S. S. F., & Jacobson, M. P. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623113-00367 · Cited by 7
Cited by
Principles for targeting RNA with drug-like small molecules
Warner, K. D., Hajdin, C. E., & Weeks, K. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.93 · Cited by 749
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 686
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
Nrf2/Keap1/ARE signaling: Towards specific regulation
Ulasov, A. V., Rosenkranz, A. A., Georgiev, G. P., & Sobolev, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120111 · Cited by 508
Orally Absorbed Cyclic Peptides
Nielsen, D. S., Shepherd, N. E., Xu, W., Lucke, A. J., Stoermer, M. J., & Fairlie, D. P. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00838 · Cited by 445
Metadata
- Authors
- Matsson, P., Doak, B. C., Over, B., & Kihlberg, J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 101
- Pages
- 42-61
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2321029289
- Cited by
- 297
- References
- 159
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.